+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Lysosomal Storage Diseases Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Lysosomal Storage Diseases Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 95 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022

  • Report
  • August 2022
  • 14 Pages
  • Global
From
Myasthenia Gravis Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Myasthenia Gravis Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2021
  • 112 Pages
  • Global
From
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 168 Pages
  • Global
From
Guillain-Barre Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Guillain-Barre Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 84 Pages
  • Global
From
Neuroimmunology Drug Development - Thematic Research - Product Thumbnail Image

Neuroimmunology Drug Development - Thematic Research

  • Report
  • April 2022
  • 163 Pages
  • Global
From
Alexion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Alexion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Alexion Pharmaceuticals Inc (ALXN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Alexion Pharmaceuticals Inc (ALXN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • April 2022
  • 79 Pages
From
Alexion Pharmaceuticals 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Alexion Pharmaceuticals 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • December 2023
  • Global
From
Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report - Product Thumbnail Image

Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

  • SWOT Analysis
  • November 2022
  • 53 Pages
From
Alexion Pharmaceuticals Inc (ALXN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Alexion Pharmaceuticals Inc (ALXN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • February 2021
  • 65 Pages
From
Loading Indicator